Literature DB >> 26927005

Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds.

Robert J Mentz1, Adrian F Hernandez2, Lisa G Berdan2, Tyrus Rorick2, Emily C O'Brien2, Jenny C Ibarra2, Lesley H Curtis2, Eric D Peterson2.   

Abstract

Randomized, clinical trials are commonly regarded as the highest level of evidence to support clinical decisions. Good Clinical Practice guidelines have been constructed to provide an ethical and scientific quality standard for trials that involve human subjects in a manner aligned with the Declaration of Helsinki. Originally designed to provide a unified standard of trial data to support submission to regulatory authorities, the principles may also be applied to other studies of human subjects. Although the application of Good Clinical Practice principles generally led to improvements in the quality and consistency of trial operations, these principles have also contributed to increasing trial complexity and costs. Alternatively, the growing availability of electronic health record data has facilitated the possibility for streamlined pragmatic clinical trials. The central tenets of Good Clinical Practice and pragmatic clinical trials represent potential tensions in trial design (stringent quality and highly efficient operations). In the present article, we highlight potential areas of discordance between Good Clinical Practice guidelines and the principles of pragmatic clinical trials and suggest strategies to streamline study conduct in an ethical manner to optimally perform clinical trials in the electronic age.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  clinical protocols; clinical trial; ethics; pragmatic clinical trial

Mesh:

Year:  2016        PMID: 26927005      PMCID: PMC4777975          DOI: 10.1161/CIRCULATIONAHA.115.019902

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  53 in total

Review 1.  Allocation concealment in randomised trials: defending against deciphering.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

2.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

3.  Randomized clinical trials: slow death by a thousand unnecessary policies?

Authors:  Salim Yusuf
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

4.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

5.  The Good Clinical Practice guideline: a bronze standard for clinical research.

Authors:  David A Grimes; David Hubacher; Kavita Nanda; Kenneth F Schulz; David Moher; Douglas G Altman
Journal:  Lancet       Date:  2005 Jul 9-15       Impact factor: 79.321

6.  Clinical trials bureaucracy: unintended consequences of well-intentioned policy.

Authors:  Robert M Califf
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

Review 7.  Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

Authors:  R Collins; S MacMahon
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

8.  The validity of a diagnosis of heart failure in a hospital discharge register.

Authors:  Erik Ingelsson; Johan Arnlöv; Johan Sundström; Lars Lind
Journal:  Eur J Heart Fail       Date:  2005-08       Impact factor: 15.534

9.  Who refuses enrollment in cardiac clinical trials?

Authors:  Mimi Sen Biswas; L Kristin Newby; Lori A Bastian; Eric D Peterson; Jeremy Sugarman
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

10.  Care patterns in Medicare and their implications for pay for performance.

Authors:  Hoangmai H Pham; Deborah Schrag; Ann S O'Malley; Beny Wu; Peter B Bach
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

View more
  29 in total

1.  Standards for Clinical Research: Keeping Pace With the Technology of the Future.

Authors:  Elliott M Antman; Barbara E Bierer
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

2.  Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study.

Authors:  Patricia O Guimarães; Arun Krishnamoorthy; Lisa A Kaltenbach; Kevin J Anstrom; Mark B Effron; Daniel B Mark; Patrick L McCollam; Linda Davidson-Ray; Eric D Peterson; Tracy Y Wang
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

3.  A Novel Patient Recruitment Strategy: Patient Selection Directly from the Community through Linkage to Clinical Data.

Authors:  Lindsay P Zimmerman; Satyender Goel; Shazia Sathar; Charon E Gladfelter; Alejandra Onate; Lindsey L Kane; Shelly Sital; Jasmin Phua; Paris Davis; Helen Margellos-Anast; David O Meltzer; Tamar S Polonsky; Raj C Shah; William E Trick; Faraz S Ahmad; Abel N Kho
Journal:  Appl Clin Inform       Date:  2018-02-14       Impact factor: 2.342

Review 4.  The need for increased pragmatism in cardiovascular clinical trials.

Authors:  Muhammad Shariq Usman; Harriette G C Van Spall; Stephen J Greene; Ambarish Pandey; Darren K McGuire; Ziad A Ali; Robert J Mentz; Gregg C Fonarow; John A Spertus; Stefan D Anker; Javed Butler; Stefan K James; Muhammad Shahzeb Khan
Journal:  Nat Rev Cardiol       Date:  2022-05-17       Impact factor: 49.421

5.  Improving the quality conduct and efficiency of clinical trials with training: Recommendations for preparedness and qualification of investigators and delegates.

Authors:  Jimmy Bechtel; Tina Chuck; Annemarie Forrest; Christine Hildebrand; Janette Panhuis; Suzanne R Pattee; Sabrina Comic-Savic; Teresa Swezey
Journal:  Contemp Clin Trials       Date:  2019-12-24       Impact factor: 2.226

6.  Improving public health by improving clinical trial guidelines and their application.

Authors:  Martin J Landray; Jeroen J Bax; Laurence Alliot; Marc Buyse; Adam Cohen; Rory Collins; Gerhard Hindricks; Stefan K James; Sile Lane; Aldo P Maggioni; Ann Meeker-O'Connell; Gunnar Olsson; Stuart J Pocock; Michael Rawlins; Jonathan Sellors; Kaori Shinagawa; Karin R Sipido; Liam Smeeth; Richard Stephens; Murray W Stewart; Wendy Gattis Stough; Fergus Sweeney; Frans Van de Werf; Kerrie Woods; Barbara Casadei
Journal:  Eur Heart J       Date:  2017-06-01       Impact factor: 29.983

Review 7.  Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.

Authors:  Stephen J Greene; Eric J Velazquez; Kevin J Anstrom; Eric L Eisenstein; Shelly Sapp; Shelby Morgan; Tina Harding; Vandana Sachdev; Fassil Ketema; Dong-Yun Kim; Patrice Desvigne-Nickens; Bertram Pitt; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2021-03-10       Impact factor: 12.035

8.  Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies.

Authors:  Si-Cong Ma; Xin-Ran Tang; Li-Li Long; Xue Bai; Jian-Guo Zhou; Zhi-Jiao Duan; Jian Wang; Qiang John Fu; Hong-Bo Zhu; Xue-Jun Guo; Yan-Pei Zhang; Ze-Qin Guo; De-Hua Wu; Zhong-Yi Dong
Journal:  Oncoimmunology       Date:  2021-04-26       Impact factor: 8.110

Review 9.  Cancer Immunoprevention and Public Health.

Authors:  Sandeep K Singh; Mehmet Tevfik Dorak
Journal:  Front Public Health       Date:  2017-05-08

10.  Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade.

Authors:  Gabrielle W Peters; Weiwei Tao; Wei Wei; Joseph A Miccio; Krishan R Jethwa; Michael Cecchini; Kimberly L Johung
Journal:  Oncologist       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.